Ayten Kandilci

417 total citations
17 papers, 335 citations indexed

About

Ayten Kandilci is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Ayten Kandilci has authored 17 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Hematology and 3 papers in Oncology. Recurrent topics in Ayten Kandilci's work include Acute Myeloid Leukemia Research (10 papers), Epigenetics and DNA Methylation (3 papers) and Genomics and Chromatin Dynamics (3 papers). Ayten Kandilci is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Epigenetics and DNA Methylation (3 papers) and Genomics and Chromatin Dynamics (3 papers). Ayten Kandilci collaborates with scholars based in United States, Türkiye and Hungary. Ayten Kandilci's co-authors include Gerard C. Grosveld, Tanya A. Kranenburg, Hiroyuki Kawagoe, Uğur Özbek, Edwin Mientjes, Kelli L. Boyd, Fadıl Ayan, Oğuz Çetinkale, Laura J. Janke and Monica Cardone and has published in prestigious journals such as Blood, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Ayten Kandilci

17 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayten Kandilci United States 10 225 111 75 51 43 17 335
Sonja Röhrs Germany 9 257 1.1× 61 0.5× 61 0.8× 39 0.8× 42 1.0× 9 369
Valentina Agnusdei Italy 10 205 0.9× 69 0.6× 65 0.9× 28 0.5× 44 1.0× 11 316
Rosalind Codrington United Kingdom 7 185 0.8× 109 1.0× 86 1.1× 26 0.5× 26 0.6× 8 339
Rozario Thomas United States 5 188 0.8× 101 0.9× 67 0.9× 19 0.4× 56 1.3× 6 300
Harry Drabkin United States 10 313 1.4× 96 0.9× 91 1.2× 33 0.6× 34 0.8× 11 441
Kathrin T. Doepfner Switzerland 6 230 1.0× 77 0.7× 34 0.5× 32 0.6× 48 1.1× 8 304
Federico Simone United States 8 327 1.5× 91 0.8× 63 0.8× 24 0.5× 48 1.1× 8 434
Nerea Marcotegui Spain 10 283 1.3× 160 1.4× 45 0.6× 16 0.3× 75 1.7× 12 374
Samuel J. Taylor United States 10 146 0.6× 123 1.1× 67 0.9× 14 0.3× 24 0.6× 21 333
Haig Inguilizian United States 5 190 0.8× 47 0.4× 83 1.1× 103 2.0× 55 1.3× 5 329

Countries citing papers authored by Ayten Kandilci

Since Specialization
Citations

This map shows the geographic impact of Ayten Kandilci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayten Kandilci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayten Kandilci more than expected).

Fields of papers citing papers by Ayten Kandilci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayten Kandilci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayten Kandilci. The network helps show where Ayten Kandilci may publish in the future.

Co-authorship network of co-authors of Ayten Kandilci

This figure shows the co-authorship network connecting the top 25 collaborators of Ayten Kandilci. A scholar is included among the top collaborators of Ayten Kandilci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayten Kandilci. Ayten Kandilci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yağcı, Ayşegül, et al.. (2024). NETosis Induced by Serum of Patients with COVID-19 is Reduced with Reparixin or Antibodies Against DEK and IL-8. Kocaeli Üniversitesi - AVESİS. 127–135. 1 indexed citations
2.
Çetįn, Metin, et al.. (2022). Doxorubicin induces prolonged DNA damage signal in cells overexpressing DEK isoform-2. PLoS ONE. 17(10). e0275476–e0275476. 2 indexed citations
3.
Oymak, Yeşim, et al.. (2020). Identification of novel TUBB1 variants in patients with macrothrombocytopenia. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(2). 490–500. 2 indexed citations
4.
Fukuda, Yu, Yao Wang, Shangli Lian, et al.. (2017). Upregulated heme biosynthesis, an exploitable vulnerability in MYCN-driven leukemogenesis. JCI Insight. 2(15). 36 indexed citations
5.
Kim, Annette S., Öner Doğan, Amma Bosompem, et al.. (2017). DEK protein level is a biomarker of CD138positive normal and malignant plasma cells. PLoS ONE. 12(5). e0178025–e0178025. 5 indexed citations
6.
Sayitoğlu, Müge, Gerard C. Grosveld, Monica Cardone, et al.. (2015). High MN1 expression increases the in vitro clonogenic activity of primary mouse B-cells. Leukemia Research. 39(8). 906–912. 3 indexed citations
7.
Kandilci, Ayten, et al.. (2013). Mapping of MN1 Sequences Necessary for Myeloid Transformation. PLoS ONE. 8(4). e61706–e61706. 9 indexed citations
8.
Ekmekçi, Cumhur Gökhan, Ayten Kandilci, Zeliha Emrence, et al.. (2012). SET oncogene is upregulated in pediatric acute lymphoblastic leukemia.. PubMed. 98(2). 252–6. 9 indexed citations
9.
Ekmekçi, Cumhur Gökhan, Ayten Kandilci, Zeliha Emrence, et al.. (2012). SET Oncogene is Upregulated in Pediatric Acute Lymphoblastic Leukemia. Tumori Journal. 98(2). 252–256. 9 indexed citations
10.
Kandilci, Ayten & Gerard C. Grosveld. (2009). Reintroduction of CEBPA in MN1-overexpressing hematopoietic cells prevents their hyperproliferation and restores myeloid differentiation. Blood. 114(8). 1596–1606. 21 indexed citations
11.
Kawagoe, Hiroyuki, Ayten Kandilci, Tanya A. Kranenburg, & Gerard C. Grosveld. (2007). Overexpression of N-Myc Rapidly Causes Acute Myeloid Leukemia in Mice. Cancer Research. 67(22). 10677–10685. 57 indexed citations
12.
Özbek, Uğur, Ayten Kandilci, Sjozèf van Baal, et al.. (2007). SET-CAN, the Product of the t(9;9) in Acute Undifferentiated Leukemia, Causes Expansion of Early Hematopoietic Progenitors and Hyperproliferation of Stomach Mucosa in Transgenic Mice. American Journal Of Pathology. 171(2). 654–666. 23 indexed citations
13.
Cardone, Monica, Ayten Kandilci, Cintia Carella, et al.. (2005). The Novel ETS Factor TEL2 Cooperates with Myc in B Lymphomagenesis. Molecular and Cellular Biology. 25(6). 2395–2405. 38 indexed citations
14.
Kandilci, Ayten & Gerard C. Grosveld. (2005). SET-induced calcium signaling and MAPK/ERK pathway activation mediate dendritic cell-like differentiation of U937 cells. Leukemia. 19(8). 1439–1445. 29 indexed citations
15.
Chan, Annie On-On, Qing Zhang, Asif Rashid, et al.. (2005). Differing DNA Methylation Patterns and Gene Mutation Frequencies in Colorectal Carcinomas from Middle Eastern Countries. Clinical Cancer Research. 11(23). 8281–8287. 42 indexed citations
16.
Kandilci, Ayten, Edwin Mientjes, & Gerard C. Grosveld. (2003). Effects of SET and SET-CAN on the differentiation of the human promonocytic cell line U937. Leukemia. 18(2). 337–340. 30 indexed citations
17.
Çetinkale, Oğuz, et al.. (1996). Neutrophil-Mediated Injury in Ischemic Skin Flaps. Annals of Plastic Surgery. 37(1). 66–74. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026